Thank you, operator, and good afternoon, everyone. Welcome to the Bionano fourth quarter 2024 financial results conference ...

OGM is used, to transform the cytogenetic workflow in four key hematologic ... Let's say they're working in AML or CML, or something of that nature. They'd want to be guided, by what's out there ...

OGM is used to transform the cytogenetic workflow in four key areas ... In that particular indication, let's say, they're working in AML or CML or something of that nature. They'd want to be ...

Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine ...

Good day, and welcome to the Bionano fourth quarter 2024 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from ...

Bionano Genomics reported a 24% year-over-year revenue decline for Q4 2024, totaling $8.2 million, alongside a modest full-year product revenue increase. The company’s stock saw a 3.79% decline ...